Johnson & Johnson COVID-19 vaccine induces immune response after 1 dose: study
(Fox News Health)

Pharmaceutical giant Johnson & Johnson on Wednesday published early data for its coronavirus vaccine, showing a lasting immune response and  tolerability among trial volunteers. According to the findings, published in the New England Journal of Medicine, over 90% of trial participants developed neutralizing antibodies 29 days after a single dose. This figure continued to increase to 100% weeks later among participants aged 18 to 55.